SynthesisFrontiers in pharmacology2023

Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus.

Xinrui Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.